Correlation Between Inventiva and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Inventiva and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inventiva and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inventiva Sa and Cue Biopharma, you can compare the effects of market volatilities on Inventiva and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inventiva with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inventiva and Cue Biopharma.
Diversification Opportunities for Inventiva and Cue Biopharma
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inventiva and Cue is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Inventiva Sa and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Inventiva is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inventiva Sa are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Inventiva i.e., Inventiva and Cue Biopharma go up and down completely randomly.
Pair Corralation between Inventiva and Cue Biopharma
Considering the 90-day investment horizon Inventiva Sa is expected to generate 0.28 times more return on investment than Cue Biopharma. However, Inventiva Sa is 3.63 times less risky than Cue Biopharma. It trades about -0.05 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.26 per unit of risk. If you would invest 271.00 in Inventiva Sa on August 29, 2024 and sell it today you would lose (7.00) from holding Inventiva Sa or give up 2.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inventiva Sa vs. Cue Biopharma
Performance |
| Timeline |
| Inventiva Sa |
| Cue Biopharma |
Inventiva and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inventiva and Cue Biopharma
The main advantage of trading using opposite Inventiva and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inventiva position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Inventiva vs. Mineralys Therapeutics, Common | Inventiva vs. Eliem Therapeutics | Inventiva vs. Anebulo Pharmaceuticals | Inventiva vs. Janux Therapeutics |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |